COLONY STIMULATING FACTOR 1 REGULATION AND ROLE IN BONE
集落刺激因子 1 的调节及其在骨中的作用
基本信息
- 批准号:6350661
- 负责人:
- 金额:$ 23.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-02-01 至 2003-01-31
- 项目状态:已结题
- 来源:
- 关键词:DNA footprinting biological signal transduction colony stimulating factor gel mobility shift assay gene expression genetically modified animals growth factor receptors hematopoietic growth factor hormone regulation /control mechanism immunoprecipitation in situ hybridization interleukin 1 laboratory mouse northern blottings nuclear factor kappa beta osteoblasts osteoclast activating factor osteoclasts parathyroid hormones phosphorylation physiologic bone resorption polymerase chain reaction site directed mutagenesis tissue /cell culture tumor necrosis factor alpha western blottings
项目摘要
The precise mechanism whereby osteoblasts mediate osteoclastic bone
resorption is unclear. One widely-held hypothesis is that activated
osteoblasts secrete cytokines that directly or indirectly influence
osteoclast formation or function. Although the nature of these putative
cytokines is unknown, compelling in vivo and in vitro data have emerged
to support a role for colony-stimulating factor-1 (CSF-1) as an
osteoblast-derived factor involved in osteoclast formation. Thus, in
vivo, deficiency of CSF-1 in the op/op osteopetrotic mouse causes a
failure of osteoclast formation and bone resorption while in vitro
studies have demonstrated that CSF-1 is critical for the proliferation
and differentiation of osteoclast progenitors, that CSF-1 stimulates
bone resorption in the fetal mouse metacarpal assay, and that CSF-1
receptors are present on osteoclasts. CSF-1 is synthesized as a soluble
or cell surface protein, and while we know that osteoblasts synthesize
both forms of CSF-1 I constitutively and in response to osteotropic
agents, little is known of their physiologic significance in bone
remodeling. Additionally, while we know that two key osteotropic agents,
parathyroid hormone (PTH) and tumor necrosis factor (TNF) increase
expression of the CSF-1 gene in osteoblasts, the precise mechanism by
which they do so is unclear. Finally, the precise physiologic role of
CSF-1 in bone remodeling in vivo is unknown. The long term goals of this
proposal are therefore: 1. to define the physiologic roles of the cell-
surface and soluble forms of CSF-1 in bone, by examining the effects of
cell-surface CSF-1 on osteoclast signaling in vitro, and by generating
two lines of genetically-altered mice that are each deficient in one of
the CSF-1 I isoforms; 2. to characterize the cellular mechanisms by
which TNF and PTH increase CSF-1 transcription in osteoblasts by
characterizing the NF-kappaB proteins that mediate TNF-induced CSF-1
gene expression and by identifying and characterizing the CSF-1 promoter
elements by which PTH mediates this response; and 3. to analyze the
role of CSF-1 in bone remodeling in vivo by characterizing in vivo and
in vitro a transgenic mouse model with targeted overexpression of CSF-1
in osteoblasts.
These studies will help to elucidate the regulation and role of a
cytokine which is critical in osteoclast development, and will improve
our understanding of the mechanisms of physiologic bone resorption, and
that induced by osteotropic agents.
成骨细胞介导骨形成的确切机制
再吸收尚不清楚。 一个被广泛接受的假设是,
成骨细胞分泌细胞因子,直接或间接影响
破骨细胞形成或功能。 虽然这些假定的性质
细胞因子是未知的,引人注目的体内和体外数据已经出现
支持集落刺激因子-1(CSF-1)作为一种
成骨细胞衍生因子参与破骨细胞的形成。 因此在
在体内,OP/OP骨硬化小鼠中CSF-1的缺乏导致
体外破骨细胞形成和骨吸收的失败
研究表明,CSF-1对于增殖至关重要
和破骨细胞祖细胞的分化,CSF-1刺激
骨吸收在胎鼠掌骨试验,和CSF-1
受体存在于破骨细胞上。 CSF-I作为可溶性的
或者细胞表面蛋白质,虽然我们知道成骨细胞合成
两种形式的CSF-1 I组成性地和响应于骨诱导性的
代理,很少有人知道他们的生理意义,在骨
重塑此外,虽然我们知道两种关键的骨诱导剂,
甲状旁腺激素(PTH)和肿瘤坏死因子(TNF)升高
CSF-1基因在成骨细胞中的表达,
他们这样做是不清楚的。 最后,
CSF-1在体内骨重建中的作用尚不清楚。这一长期目标
因此,建议是:1. 来定义细胞的生理功能
骨中CSF-1的表面和可溶形式,通过检查
细胞表面CSF-1对体外破骨细胞信号传导的影响,
两种基因改变的小鼠,每一种都有一种缺陷,
CSF-II同种型; 2. 来描述细胞机制,
TNF和PTH通过以下方式增加成骨细胞中CSF-1的转录:
表征介导TNF诱导的CSF-1的NF-κ B蛋白
基因表达,并通过鉴定和表征CSF-1启动子
PTH介导这种反应的元件;和3. 分析
CSF-1在体内骨重建中的作用,
体外建立CSF-1靶向过表达转基因小鼠模型
在成骨细胞中。
这些研究将有助于阐明调节和作用,
细胞因子,这是破骨细胞发展的关键,并将改善
我们对生理性骨吸收机制的理解,
由骨诱导剂引起的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KARL Leonard INSOGNA其他文献
KARL Leonard INSOGNA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KARL Leonard INSOGNA', 18)}}的其他基金
Different Roles for Colony Stimulating Factor 1 Isoforms in Anabolic Therapy for Low Bone Mass
集落刺激因子 1 同工型在低骨量合成代谢治疗中的不同作用
- 批准号:
10585240 - 财政年份:2023
- 资助金额:
$ 23.07万 - 项目类别:
An ounce of prevention: stopping menopausal bone loss before it starts
一盎司的预防:在更年期骨质流失开始之前阻止它
- 批准号:
10324591 - 财政年份:2021
- 资助金额:
$ 23.07万 - 项目类别:
The Role of Sphingosine Kinases in Bone Anabolism
鞘氨醇激酶在骨合成代谢中的作用
- 批准号:
9274156 - 财政年份:2016
- 资助金额:
$ 23.07万 - 项目类别:
A novel SATB2 mutation illuminates bone anabolism
一种新的 SATB2 突变阐明了骨合成代谢
- 批准号:
8874913 - 财政年份:2014
- 资助金额:
$ 23.07万 - 项目类别:
A novel SATB2 mutation illuminates bone anabolism
一种新的 SATB2 突变阐明了骨合成代谢
- 批准号:
8758799 - 财政年份:2014
- 资助金额:
$ 23.07万 - 项目类别:
Calcitonin for Treating X-linked Hypophosphatemia
降钙素治疗 X 连锁低磷血症
- 批准号:
8319251 - 财政年份:2011
- 资助金额:
$ 23.07万 - 项目类别:
Calcitonin for treating X-linked hypophosphatemia
降钙素治疗 X 连锁低磷血症
- 批准号:
8193343 - 财政年份:2011
- 资助金额:
$ 23.07万 - 项目类别:
Conditional Deletion of PTHrP in Articular Chondrocytes
关节软骨细胞中 PTHrP 的条件性缺失
- 批准号:
7609121 - 财政年份:2008
- 资助金额:
$ 23.07万 - 项目类别:
Conditional Deletion of PTHrP in Articular Chondrocytes
关节软骨细胞中 PTHrP 的条件性缺失
- 批准号:
7509044 - 财政年份:2007
- 资助金额:
$ 23.07万 - 项目类别:
Microcomputed tomography device (Scanco microCT35)
微型计算机断层扫描设备(Scanco microCT35)
- 批准号:
7389328 - 财政年份:2007
- 资助金额:
$ 23.07万 - 项目类别:
相似海外基金
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
- 批准号:
6238317 - 财政年份:1997
- 资助金额:
$ 23.07万 - 项目类别:
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
- 批准号:
5210031 - 财政年份:
- 资助金额:
$ 23.07万 - 项目类别: